The ligand-receptor interactions were quite uniform across different CD34 + CML cells and NK cell subpopulations, although interactions against CD34 + CML with low BCR-ABL1 activity were scarce. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.